If you’ve spent more than five minutes browsing the world of research peptides, you’ve seen the badge. It’s usually gold or green, slapped onto a product page, and reads: "Third-Party Tested." In an industry that moves as fast as biotechnology, that label is supposed to be your safety net. But...

A JAMA Network Open study built from Reddit posts is notable in itself: mainstream medical research is now examining the gray market through the social-media data it generates. Published on 14 October 2026, the analysis offers a large-scale snapshot of self-reported symptoms among people discussing nonapproved retatrutide online. But a...

A vial’s label can name a compound. It cannot prove what is inside. That distinction was stark in a 14 September 2026 safety advisory from Australia’s Therapeutic Goods Administration (TGA). After a consumer was hospitalised with uncontrollable vomiting and an oesophageal tear, testing of an unmarked vial sold as retatrutide...